BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15454728)

  • 1. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene.
    Gnerre C; Blättler S; Kaufmann MR; Looser R; Meyer UA
    Pharmacogenetics; 2004 Oct; 14(10):635-45. PubMed ID: 15454728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
    Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
    J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnane X receptor is a target of farnesoid X receptor.
    Jung D; Mangelsdorf DJ; Meyer UA
    J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
    Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
    Zhang J; Kuehl P; Green ED; Touchman JW; Watkins PB; Daly A; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Wrighton SA; Hancock M; Kim RB; Strom S; Thummel K; Russell CG; Hudson JR; Schuetz EG; Boguski MS
    Pharmacogenetics; 2001 Oct; 11(7):555-72. PubMed ID: 11668216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
    Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
    J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes.
    Song X; Xie M; Zhang H; Li Y; Sachdeva K; Yan B
    Drug Metab Dispos; 2004 Jan; 32(1):35-42. PubMed ID: 14709618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
    Staudinger J; Liu Y; Madan A; Habeebu S; Klaassen CD
    Drug Metab Dispos; 2001 Nov; 29(11):1467-72. PubMed ID: 11602523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor.
    Casabar RC; Das PC; Dekrey GK; Gardiner CS; Cao Y; Rose RL; Wallace AD
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):335-43. PubMed ID: 20361990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element.
    El-Sankary W; Bombail V; Gibson GG; Plant N
    Drug Metab Dispos; 2002 Sep; 30(9):1029-34. PubMed ID: 12167569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents.
    Mani S; Huang H; Sundarababu S; Liu W; Kalpana G; Smith AB; Horwitz SB
    Clin Cancer Res; 2005 Sep; 11(17):6359-69. PubMed ID: 16144941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics.
    LeCluyse EL
    Chem Biol Interact; 2001 May; 134(3):283-9. PubMed ID: 11336976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.
    Xie W; Barwick JL; Simon CM; Pierce AM; Safe S; Blumberg B; Guzelian PS; Evans RM
    Genes Dev; 2000 Dec; 14(23):3014-23. PubMed ID: 11114890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of CYP expression in hepatoma cells stably transfected by chimeric nuclear receptors.
    Küblbeck J; Reinisalo M; Mustonen R; Honkakoski P
    Eur J Pharm Sci; 2010 Jul; 40(4):263-72. PubMed ID: 20381613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
    Schuetz EG; Strom S; Yasuda K; Lecureur V; Assem M; Brimer C; Lamba J; Kim RB; Ramachandran V; Komoroski BJ; Venkataramanan R; Cai H; Sinal CJ; Gonzalez FJ; Schuetz JD
    J Biol Chem; 2001 Oct; 276(42):39411-8. PubMed ID: 11509573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.
    Jones SA; Moore LB; Shenk JL; Wisely GB; Hamilton GA; McKee DD; Tomkinson NC; LeCluyse EL; Lambert MH; Willson TM; Kliewer SA; Moore JT
    Mol Endocrinol; 2000 Jan; 14(1):27-39. PubMed ID: 10628745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CYP3A4 and CYP2B6 expression by liver X receptor agonists.
    Duniec-Dmuchowski Z; Ellis E; Strom SC; Kocarek TA
    Biochem Pharmacol; 2007 Nov; 74(10):1535-40. PubMed ID: 17825266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.